Gan & Lee Pharmaceuticals
SSE:603087

Watchlist Manager
Gan & Lee Pharmaceuticals Logo
Gan & Lee Pharmaceuticals
SSE:603087
Watchlist
Price: 44.81 CNY -4.7% Market Closed
Market Cap: 26.5B CNY
Have any thoughts about
Gan & Lee Pharmaceuticals?
Write Note

Wall Street
Price Targets

Price Targets Summary
Gan & Lee Pharmaceuticals

Wall Street analysts forecast Gan & Lee Pharmaceuticals stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Gan & Lee Pharmaceuticals is 69.36 CNY with a low forecast of 68.68 CNY and a high forecast of 71.4 CNY.

Lowest
Price Target
68.68 CNY
53% Upside
Average
Price Target
69.36 CNY
55% Upside
Highest
Price Target
71.4 CNY
59% Upside
Gan & Lee Pharmaceuticals Competitors:
Price Targets
KNSA
Kiniksa Pharmaceuticals Ltd
73% Upside
MOLN
Molecular Partners AG
131% Upside
RARE
Ultragenyx Pharmaceutical Inc
100% Upside
ARX
Aroa Biosurgery Ltd
45% Upside
MYGN
Myriad Genetics Inc
57% Upside
TNG
Transgene SA
280% Upside
688373
Shanghai MicuRx Pharmaceutical Co Ltd
39% Upside
PHM
Pharma Mar SA
6% Upside

Revenue
Forecast

Revenue Estimate
Gan & Lee Pharmaceuticals

For the last 5 years the compound annual growth rate for Gan & Lee Pharmaceuticals's revenue is 2%. The projected CAGR for the next 3 years is 26%.

2%
Past Growth
26%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Gan & Lee Pharmaceuticals

For the last 5 years the compound annual growth rate for Gan & Lee Pharmaceuticals's operating income is -29%. The projected CAGR for the next 3 years is 95%.

-29%
Past Growth
95%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Gan & Lee Pharmaceuticals

For the last 5 years the compound annual growth rate for Gan & Lee Pharmaceuticals's net income is -18%. The projected CAGR for the next 3 years is 63%.

-18%
Past Growth
63%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Gan & Lee Pharmaceuticals's stock price target?
Price Target
69.36 CNY

According to Wall Street analysts, the average 1-year price target for Gan & Lee Pharmaceuticals is 69.36 CNY with a low forecast of 68.68 CNY and a high forecast of 71.4 CNY.

What is Gan & Lee Pharmaceuticals's Revenue forecast?
Projected CAGR
26%

For the last 5 years the compound annual growth rate for Gan & Lee Pharmaceuticals's revenue is 2%. The projected CAGR for the next 3 years is 26%.

What is Gan & Lee Pharmaceuticals's Operating Income forecast?
Projected CAGR
95%

For the last 5 years the compound annual growth rate for Gan & Lee Pharmaceuticals's operating income is -29%. The projected CAGR for the next 3 years is 95%.

What is Gan & Lee Pharmaceuticals's Net Income forecast?
Projected CAGR
63%

For the last 5 years the compound annual growth rate for Gan & Lee Pharmaceuticals's net income is -18%. The projected CAGR for the next 3 years is 63%.

Back to Top